CryptoNews

Lido Ends Staking on Polygon; Refocuses on Ethereum – Finance Bitcoin News

The Lido community has voted to end staking services on Polygon, due to significant challenges that has limited adoption.

Lido Shuts Down Polygon Staking

Lido Finance has announced it will be effectively discontinuing its staking service on Polygon. According to a Dec. 16 blogpost, the decision was reached after an extensive decentralized autonomous organization (DAO) forum discussion and a community vote with the majority of Lido token holders voting to end Lido operations on Polygon.

As part of the process, stMATIC holders will immediately stop receiving network rewards and users can unstake their MATIC through the Lido on Polygon frontend until June 16, 2025. After June 16, 2025, withdrawals will remain possible but only through explorer tools.

Shard Labs made the initial idea for Lido (LDO) on Polygon in 2021. Although, it began with high expectations, Lido on Polygon experienced significant challenges with limited user adoption, inadequate rewards, resource-intensive maintenance needs, and changing ecosystem dynamics.

The changing nature of decentralized finance (defi) activity has been a major obstacle, especially with the growing emphasis on zkEVM solutions. Lido’s potential as a fundamental defi building element on Polygon has been impacted by this shift which has decreased demand for liquid staking solutions on Polygon.

These series of events along with the recent governance decisions by LDO token holders’ to strategically concentrate on Ethereum has contributed to Lido’s shutdown on Polygon.

Source: Bitcoin

Related posts
AI & RoboticsNews

Nvidia and DataStax just made generative AI smarter and leaner — here’s how

AI & RoboticsNews

OpenAI opens up its most powerful model, o1, to third-party developers

AI & RoboticsNews

UAE’s Falcon 3 challenges open-source leaders amid surging demand for small AI models

DefenseNews

Army, Navy conduct key hypersonic missile test

Sign up for our Newsletter and
stay informed!

Share Your Thoughts!

This site uses Akismet to reduce spam. Learn how your comment data is processed.